179688-29-0: Erlotinib lactum Impurity

Status: In-stock

Erlotinib Lactum Impurity (CAS No.179688-29-0) or 6,7-bis(2-Methoxyethoxy)-3,4-dihydroquinazolin-4-one. Erlotinib is a oral low molecular weight quinazoline which selectively and reversibly inhibit Tyrosine Kinase(TK). It is specific epidermal growth factor receptor.

Additional information on CAS 179688-29-0

Catalogue No. VL2460009
CAS No. 179688-29-0
Molecular Formula C₁₄H₁₈N₂O₅
Molecular Weight 294.3
Parent drug Erlotinib
IUPAC Name 6, 7-bis(2-Methoxyethoxy)-3, 4-dihydroquinazolin-4-one
Synonyms 6, 7-Di(2-methoxyethoxy)-3, 4-dihydroquinazolin-4-one; 6, 7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one; CP-380736;
References "Bareschino, M. A., et al. “Erlotinib in Cancer Treatment.” Annals of Oncology, vol. 18, June 2007, pp. vi35–41, https://doi.org/10.1093/annonc/mdm222. ?Pérez-Soler, Román, et al. ""Determinants of tumor response and survival with erlotinib in patients with non—small-cell lung cancer."" Journal of clinical oncology 22.16 (2004): 3238-3247."
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

179688-29-0: Erlotinib lactum Impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.